1. Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
- Author
-
Yun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, Angeline Rouers, Zi Wei Chang, Jean-Marc Chavatte, Pei Xiang Hor, Chiew Yee Loh, Yuling Huang, Yong Jie Tan, Bei Wang, Eve Zi Xian Ngoh, Siti Nazihah Mohd Salleh, Raphael Tze Chuen Lee, Georgina Lim, NCID Study Group, COVID-Study Group, Sebastian Maurer-Stroh, Cheng-I Wang, Yee‐Sin Leo, Raymond T. P. Lin, Meng Chon Lam, David C. Lye, Barnaby Edward Young, Lisa F. P. Ng, and Laurent Renia
- Subjects
Medicine ,Science - Abstract
Abstract Identification of the risk factors and the high-risk groups which are most vulnerable is critical in COVID-19 disease management at a population level. Evaluating the efficacy of vaccination against infections is necessary to determine booster vaccination strategies for better protection in high-risk groups. In this study, we recruited 158 mRNA-vaccinated individuals during the Delta wave of SARS-CoV-2 infections in Singapore and examined the antibody profiles of infected individuals. We found that, despite high exposure due to communal living conditions in proximity, 4% of individuals (6/158) had PCR-confirmed infections and 96% (152/158) remained uninfected. Time-course analysis of the antibody profile at the start and the end of quarantine period showed Delta-specific boosting of anti-spike antibody response in 57% of the uninfected individuals (86/152). In the remaining 43% of the uninfected individuals (66/152) with no Delta-specific antibody boost, we found a higher Delta-specific antibody response at the start of quarantine period, which correlated with higher Delta pseudovirus neutralizing capacity. Our findings indicate that a higher basal variant-specific antibody response in the mRNA-vaccinated individuals contributes to better protection against infections by the new emerging SARS-CoV-2 variants.
- Published
- 2023
- Full Text
- View/download PDF